Results of the current study confirm that VEGF promotes EMT in VEGFR2-expressing tumor cells, and suppression of the VEGF/VEGFR2 system may attenuate this process in favor of metastasis inhibition. The gene discussed is VEGFA; the disease is neoplasm.